First use of tofacitinib to treat an immune checkpoint inhibitor-induced arthritis.
Murray K, Floudas A, Murray C, Fabre A, Crown J, Fearon U, Veale D.
BMJ Case Rep. 2021 Feb 4.
Murray K, Quinn S, Turk M, O’Rourke A, Molloy E, O’Neill L, Mongey AB, Fearon U, Veale DJ
Rheumatology (Oxford). 2021 Feb 1.
McGarry T, Hanlon MM, Marzaioli V, Cunningham CC, Krishna V, Murray K, Hurson C, Gallagher P, Nagpal S, Veale DJ, Fearon U.
Clin Transl Immunology. 2021 Jan 19
Long-term remission and biologic persistence rates: 12-year real-world data.
Murray K, Turk M, Alammari Y, Young F, Gallagher P, Saber T, Fearon U, Veale DJ.
Arthritis Res Ther. 2021 Jan. 13
The PD-1:PD-L1 axis in Inflammatory Arthritis.
Canavan M, Floudas A, Veale DJ, Fearon U.
BMC Rheumatol. 2021 Jan 11.